- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT05562674
Virkningen af VVV-gruppen for veteraner med SMI (VVV)
28. april 2026 opdateret af: VA Office of Research and Development
Virkning af veteranstemmer og -visioner Peer Support Groups på social integration for veteraner med SMI/psykose
Veteraner med alvorlig psykisk sygdom (SMI) kæmper med social integration - deltagelse i arbejde, bolig og medborgerskab - på grund af symptomer, stigmatisering og psykosociale udfordringer.
På trods af betydelige VA-bestræbelser på at yde mental sundhedspleje til veteraner med SMI, mangler der programmer, der fremmer social integration.
Veteraner med SMI er i særlig høj risiko for dårlig social integration og selvmordstanker under COVID-19-pandemien.
Dette projekt løser dette behov med en gruppebaseret, peer specialist (PS) co-faciliteret psykosocial intervention for veteraner med SMI, kaldet "Veteran Voices and Visions" (VVV).
VVV henvender sig til veteraner med SMI, der oplever psykose, en gruppe, der især har behov for støtte til social integration.
Virtuelle VVV-grupper ledes i fællesskab af VA mentale sundhedsklinikere (MHC'er) og PS'er via online videokonference.
Tilgangen letter gruppesamhørighed omkring og normalisering af de almindelige psykotiske symptomer på SMI: hallucinationer, vrangforestillinger og social isolation.
Denne intervention har potentialet til at skabe og fremme et støttende fællesskab, der forbedrer deltagernes sociale integration ved at reducere deres nød og selvstigmatisering og øge deres selveffektivitet.
Studieoversigt
Status
Afsluttet
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
This is a single arm study of feasibility and acceptability of the adapted manual and protocol we have developed in preparation for a larger efficacy trial.
Undersøgelsestype
Interventionel
Tilmelding (Faktiske)
28
Fase
- Ikke anvendelig
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiesteder
-
-
California
-
West Los Angeles, California, Forenede Stater, 90073-1003
- VA Greater Los Angeles Healthcare System, West Los Angeles, CA
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
18 år og ældre (Voksen, Ældre voksen)
Tager imod sunde frivillige
Ingen
Beskrivelse
Inklusionskriterier:
- DSM 5 diagnoser af skizofreni, skizoaffektiv lidelse, bipolar med psykose, depression med psykose, uspecificeret psykose
Ekskluderingskriterier:
- Stof-induceret psykose,
- klinisk signifikant neurologisk sygdom,
- anamnese med alvorlig hovedskade med tab af bevidsthed > 1 time.
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: N/A
- Interventionel model: Enkelt gruppeopgave
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Veteran Voices & Visions (VVV)
Veteran Voices and Visions is the experimental condition.
It is a group of Veterans who are experiencing chronic psychosis.
The group meets for 60 minutes, weekly, for 12 weeks.
The investigators adapted a manual and protocol for the VA and this study is testing this manual.
This is a single-arm study.
|
Clinician and peer co-led meaning-oriented support group based on the Hearing Voices approach.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
The Psychotic Symptoms Rating Scale (PSYRATS-AH)
Tidsramme: 12 weeks after the initiation of the intervention
|
PSYRATS-AH is an 11-item scale which assesses the frequency, duration, severity, loudness, location, negative content, and controllability of voices, intensity of distress, and beliefs about origin of voices and disruptiveness.
Minimum score is 0, maximum 44.
Any decrease in overall score is indicative of decreased distress.
|
12 weeks after the initiation of the intervention
|
|
Role Functioning Scale Total Score
Tidsramme: 12 weeks after the initiation of the intervention
|
The Role Functioning Scale (RFS) is a broad global integration index across the 4 domains: work, independent living, and family relationships and immediate social network relationships.
Each domain ranges from 1 (worst) to 7 (best), for a total score range of minimum 4, maximum 28.
|
12 weeks after the initiation of the intervention
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Beliefs About Voices Questionnaire-R Omnipotence Subscale
Tidsramme: 12 weeks
|
The Revised Beliefs About Voices Questionnaire (BAVQ-R) is a measure of a person's beliefs, emotions and behavior in response to voices.
The 35-item questionnaire forms five sub-scales: three concerning beliefs about the dominant voice (malevolence, benevolence and omnipotence), and two concerning emotional and behavioral reactions (resistance, and engagement).
The omnipotence subscale measures the amount of omnipotence the subjects attributes to their voice.
Minimum score is 0, maximum is 18, higher score indicates greater omnipotence.
|
12 weeks
|
|
Beliefs About Voices Questionnaire-R Malevolence Subscale
Tidsramme: 12 weeks
|
The Revised Beliefs About Voices Questionnaire (BAVQ-R) is a measure of a person's beliefs, emotions and behavior in response to voices.
The 35-item questionnaire forms five sub-scales: three concerning beliefs about the dominant voice (malevolence, benevolence and omnipotence), and two concerning emotional and behavioral reactions (resistance, and engagement).
The malevolence subscale measures the amount of malevolence the subjects attribute to their voice.
Minimum score is 0, maximum is 18, higher score indicates greater malevolence.
|
12 weeks
|
|
Beliefs About Voices Questionnaire-R Benevolence Subscale
Tidsramme: 12 weeks
|
The Revised Beliefs About Voices Questionnaire (BAVQ-R) is a measure of a person's beliefs, emotions and behavior in response to voices.
The 35-item questionnaire forms five sub-scales: three concerning beliefs about the dominant voice (malevolence, benevolence and omnipotence), and two concerning emotional and behavioral reactions (resistance, and engagement).
The benevolence subscale measures the amount of benevolence the subjects attribute to their voice.
Minimum score is 0, maximum is 18, higher score indicates greater benevolence.
|
12 weeks
|
|
Beliefs About Voices Questionnaire-R Resistance Subscale
Tidsramme: 12 weeks
|
The Revised Beliefs About Voices Questionnaire (BAVQ-R) is a measure of a person's beliefs, emotions and behavior in response to voices.
The 35-item questionnaire forms five sub-scales: three concerning beliefs about the dominant voice (malevolence, benevolence and omnipotence), and two concerning emotional and behavioral reactions (resistance, and engagement).
The resistance subscale measures the degree to which the subject willingly engages with their voices.
Minimum score is 0, maximum is 18, higher score indicates greater resistance and less engagement.
|
12 weeks
|
|
Beliefs About Voices Questionnaire-R Emotional Resistance Subscale
Tidsramme: 12 weeks
|
The Revised Beliefs About Voices Questionnaire (BAVQ-R) is a measure of a person's beliefs, emotions and behavior in response to voices.
The 35-item questionnaire forms five sub-scales: three concerning beliefs about the dominant voice (malevolence, benevolence and omnipotence), and two concerning emotional and behavioral reactions (resistance, and engagement).
The emotional resistance subscale measures the degree to which the subject willingly engages with their voices emotionally.
Minimum score is 0, maximum 12, higher score indicates greater resistance and less engagement.
|
12 weeks
|
|
Beliefs About Voices Questionnaire-R Behavioral Resistance Subscale
Tidsramme: 12 weeks
|
The Revised Beliefs About Voices Questionnaire (BAVQ-R) is a measure of a person's beliefs, emotions and behavior in response to voices.
The 35-item questionnaire forms five sub-scales: three concerning beliefs about the dominant voice (malevolence, benevolence and omnipotence), and two concerning emotional and behavioral reactions (resistance, and engagement).
The behavioral resistance subscale measures the degree to which the subject willingly engages with their voices behaviorally.
Minimum score is 0, maximum is 15, higher score indicates greater resistance and less engagement.
|
12 weeks
|
|
Beliefs About Voices Questionnaire-R Engagement Subscale
Tidsramme: 12 weeks
|
The Revised Beliefs About Voices Questionnaire (BAVQ-R) is a measure of a person's beliefs, emotions and behavior in response to voices.
The 35-item questionnaire forms five sub-scales: three concerning beliefs about the dominant voice (malevolence, benevolence and omnipotence), and two concerning emotional and behavioral reactions (resistance, and engagement).
The engagement subscale measures the degree to which the subject willingly engages with their voices.
Minimum score is 0, maximum 27, higher score indicates greater engagement.
|
12 weeks
|
|
Beliefs About Voices Questionnaire - R Emotional Engagement Subscale
Tidsramme: 12 weeks
|
The Revised Beliefs About Voices Questionnaire (BAVQ-R) is a measure of a person's beliefs, emotions and behavior in response to voices.
The 35-item questionnaire forms five sub-scales: three concerning beliefs about the dominant voice (malevolence, benevolence and omnipotence), and two concerning emotional and behavioral reactions (resistance, and engagement).
The emotional engagement subscale measures the degree to which the subject willingly engages with their voices emotionally.
Minimum score is 0, maximum 15, higher score indicates greater engagement.
|
12 weeks
|
|
Beliefs About Voices Questionnaire - R Behavioral Engagement Subscale
Tidsramme: 12 weeks
|
The Revised Beliefs About Voices Questionnaire (BAVQ-R) is a measure of a person's beliefs, emotions and behavior in response to voices.
The 35-item questionnaire forms five sub-scales: three concerning beliefs about the dominant voice (malevolence, benevolence and omnipotence), and two concerning emotional and behavioral reactions (resistance, and engagement).
The behavioral engagement subscale measures the degree to which the subject willingly engages with their voices behaviorally.
Minimum score is 0, maximum is 12, Higher score indicates greater engagement.
|
12 weeks
|
|
Peters Delusion Inventory Count
Tidsramme: 12 weeks
|
The Peters Delusion Inventory is a 21-item measure of distress, preoccupation, and conviction of delusions with high convergent, discriminant, and criterion validity.
Minimum score is 0, maximum is 21.
Higher score indicates worse outcome.
|
12 weeks
|
|
Peters Delusion Inventory Distress Subscale
Tidsramme: 12 weeks
|
The Peters Delusion Inventory is a 21-item measure of distress, preoccupation, and conviction of delusions with high convergent, discriminant, and criterion validity.
Minimum score is 0, maximum is 60.
Higher score indicates worse outcome.
The distress subscale measures the amount of cumulative distress associated with all reported delusions.
|
12 weeks
|
|
Brief Psychiatric Rating Scale Global Score
Tidsramme: 12 weeks
|
Assesses for psychiatric symptoms-specifically the positive/negative symptom assess subscale scores and suicidal ideation.
Minimum score is 24, maximum is 168.
Higher score indicates worse outcome.
|
12 weeks
|
|
Questionnaire on the Process of Recovery
Tidsramme: 12 weeks
|
The Questionnaire on the Process of Recovery (QPR) is an instrument co-developed by service users and re-searchers about recovery from psychosis with 15 items measuring connectedness, hope, identity, meaning, and empowerment.
The QPR has demonstrated high internal and convergent validity as well as sensitivity to change.
Minimum score is 0, maximum is 60.
Higher score indicates better outcome.
|
12 weeks
|
|
Generalized Self-Efficacy Scale
Tidsramme: 12 weeks
|
Generalized Self-Efficacy Scale is a 10-item measure of self-efficacy that has been shown to be valid and reliable and has been used with schizophrenia.
Range, 10-40.
Higher score indicates better outcome.
|
12 weeks
|
|
Internalized Stigma of Mental Illness
Tidsramme: 12 weeks
|
The Internalized Stigma of Mental Illness scale is a 29-item measure of internalized stigma with five subscales (alienation, stereotype endorsement, discrimination, experience, social withdrawal, and stigma resistance).
It has been used with schizophrenia and is reliable (a = .90)
and valid.
Range, 1-4, as all item scores are averaged.
Higher score indicates worse outcome.
|
12 weeks
|
|
UCLA Loneliness Scale
Tidsramme: 12 weeks
|
UCLA Loneliness Scale, a 20-item scale measuring subjective experience of loneliness, is considered the gold standard measure of perceived social isolation and is highly reliable (a = .89-.94) and valid.
It has been used with SSD.
Range, 20-80.
Higher score indicates worse outcome.
|
12 weeks
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Efterforskere
- Ledende efterforsker: Ippolytos A Kalofonos, MD PhD MPH, VA Greater Los Angeles Healthcare System, West Los Angeles, CA
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart (Faktiske)
18. marts 2024
Primær færdiggørelse (Faktiske)
1. marts 2025
Studieafslutning (Faktiske)
1. marts 2025
Datoer for studieregistrering
Først indsendt
27. september 2022
Først indsendt, der opfyldte QC-kriterier
27. september 2022
Først opslået (Faktiske)
3. oktober 2022
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
1. maj 2026
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
28. april 2026
Sidst verificeret
1. april 2026
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
- Neurologiske manifestationer
- Sygdomme i nervesystemet
- Skizofrenispektrum og andre psykotiske lidelser
- Psykiske lidelser
- Neuroadfærdsmæssige manifestationer
- Perceptuelle forstyrrelser
- Patologiske tilstande, tegn og symptomer
- Tegn og symptomer
- Psykotiske lidelser
- Hallucinationer
- Muskuloskeletale og neurale fysiologiske fænomener
- Cellefysiologiske fænomener
- Biokemiske fænomener
- Kemiske fænomener
- Nervesystemets fysiologiske fænomener
- Okulære fysiologiske fænomener
- Sensation
- Signaltransduktion
- Lyssignaltransduktion
- Vision, okulær
Andre undersøgelses-id-numre
- D4376-P
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
JA
IPD-planbeskrivelse
PI'en vil skabe afidentificerede, undersøgelsesspecifikke datasæt, der inkluderer alle variabler i en publikation.
Noget tab af information kan forekomme i betragtning af behovet for at fjerne PHI.
PI'en vil erstatte person- og lægestationsnumre med studiespecifikke numre.
PI vil droppe fødselsdatoen og erstatte alder med alderskategorier i overensstemmelse med PHI-kravene for personer 85 år og ældre.
Datoer for service vil blive erstattet med årgangsdukker.
IPD-delingstidsramme
Datasæt, der opfylder VA-standarderne for offentliggørelse, vil blive gjort tilgængelige inden for 1 år efter offentliggørelsen.
IPD-delingsadgangskriterier
Inden distributionen vil en lokal privatlivsansvarlig bekræfte, at alle datasæt ikke indeholder nogen PHI.
Endelige datasæt vil blive vedligeholdt lokalt, indtil ressourcer på virksomhedsniveau bliver tilgængelige for langtidslagring og adgang.
Vejledning om forespørgsel og distributionsprocesser vil blive leveret af ORD.
De, der anmoder om data, vil blive bedt om at underskrive en aftale.
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Ingen
Studerer et amerikansk FDA-reguleret enhedsprodukt
Ingen
produkt fremstillet i og eksporteret fra U.S.A.
Ingen
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .